BASEL, Switzerland and NUTLEY, N.J., Oct. 1 /PRNewswire/ -- This month, Med Ad News, one of the pharmaceutical industry's leading business and marketing publications, selected Roche out of 50 companies as the "2007 Pharmaceutical Company of the Year." This marks the first time Roche has received this distinction.
Roche's selection results from the company's focus on innovation-driven healthcare as demonstrated by its top seven products that have helped patients worldwide and are categorized as blockbusters, individually earning over a billion dollars; seven major marketing approvals in the first half of 2007; and a number of new innovative medicines to be launched in the future.
"Roche is thrilled to be recognized as 'Company of the Year' by Med Ad News," said Franz B. Humer, Roche Chairman and CEO. "Roche will continue efforts to be an industry leader by remaining focused on unmet medical needs and developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life."
According to Med Ad News, Roche was selected as Company of the Year
based on a number of key factors, including record gains in 2006 and 2007
through organic growth and the company's earnings performance, strength in
the pharmaceuticals division, solid growth in its product line, including
several billion dollar products. Med Ad News also highlighted the company's
new R&D model, which was implemented earlier this year, and potential
promising pipeline candidates, key acquisitions and alliances, and
recognition as an employer of choice by numerous organizations and
publications. While the distinction is for pharmaceutical company of the
year, Med Ad News also cited the company's leadership in in-vitro
diagnostics, key diagnostic products and alliances, as well as the pending
transition in management following the announcement that Severin Schwan
will assume the position of CEO in March 2008.
Copyright©2007 PR Newswire.
All rights reserved